Lymphocyte to Procalcitonin Ratio in Covid-19 Patients

Suleyman Demirel University

Status: Active, not recruiting

Conditions: COVID-19

Study type: Observational

Funder types: Other

Identifiers

NCT06620159

SuleymanDU-MED-TEŞ-02

Details and patient eligibility

About

The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age.

Full description

The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age. The auc value, PPV and specificity of the lymphocyte/procalcitonin ratio were higher than the lymphocyte/CRP ratio.

Enrollment: 535 patients

Sex: All

Ages: 23 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Covid19 PCR test positive

Exclusion criteria

• Pregnancy Under 18 years old

Trial design

535 participants in 1 patient group

Covid19(+)

Description:

Covid19 patients with a positive PCR test